Stating that 415 people die on roads in India every day, Road Transport and Highways Minister Gadkari said there is a need to expedite the task of saving the lives of people

The pre-prints or preliminary reports of research work related to Covaxin, which are yet to be peer-reviewed are already posted on pre-print servers like bioRxiv, medRxiv and Research Square

A team from Precisa Medicamentos visited the Bharat Biotech's Hyderabad facility last week to discuss potential export possibilities of Covaxin with Chairman Dr Krishna Ella on the January 7-8

The central bank said the statutory inspection of Deutsche Bank's financial position as on March 31, 2019 and the Risk Assessment Report revealed non-compliance with the 'Reserve Bank of India (Interest Rate on Deposits) Directions, 2016'

The Covishield vaccine is being produced in India by the Serum Institute of India at their facility in Pune. For the vaccination drive on January 16, 476 boxes of Covishield vaccine are being supplied out of the Pune Aiport to 13 cities today

NITI Aayog VC Rajiv Kumar was commenting on the first advance estimates (AE) of national income released by the National Statistical Office (NSO) on Thursday, which projected 7.7 per cent contraction in GDP for the current fiscal year

Prime Minister Narendra Modi will meet economists on Friday to seek their inputs for the upcoming Union Budget 2021 for boosting economic growth

Coronavirus vaccine in India: Talking about the vaccine, the minister urged people not to pay heed to any rumours. He said India became free of polio disease because of the vaccine

As farmers continue their protests demanding repealing of the three new laws, Kumar also emphasised that continued negotiations with protesting farmers is of course the way forward

The UK has identified a fast-spreading new variant of coronavirus that is 70% more transmissible than existing strains. A similar mutation was also reported from South Africa and countries like Netherlands and Denmark

The new strain of COVID-19 in the United Kingdom has increased transmissibility. This mutation is not affecting the severity of the disease. Case fatality is not affected by this mutation, said Dr VK Paul, Member (Health), NITI Aayog

Union Health Minister Harsh Vardhan was speaking while chairing the 22nd meeting of the high-level Group of Ministers (GoM) on COVID-19 through video-conferencing on Saturday

The coordination committee of agitating farmer groups says that by attributing political sides to farmer struggles, PM Modi instead of addressing the issue of repeal of the three contentious farm laws has reduced himself to a party leader

Farmers' agitation: Kejriwal said he will observe the fast in response to a call given by the agitating farmers and urged his Aam Aadmi Party (AAP) volunteers, supporters, as well as the people of the country to join in

Constitution of committees and their responsibilities are in sync with broad instructions issued by Centre; decision to provide vaccine for free was conveyed by Chief Minister Pinarayi Vijayan at a presser on Saturday

Indian-origin health expert Anil Soni to lead The WHO Foundation as first CEO; Mt Everest gets even higher; China and Nepal announce revised height of Mt Everest; Indian tech players secured $38 billion from investors amid COVID-19 pandemic, says NITI Aayog CEO Amitabh Kant. Watch this and more news on News Blast.

DCGI actively considering 3 COVID-19 vaccines for emergency use: Health Ministry Three COVID-19 vaccines candidates, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration by India's drug regulator and there is hope that getting an early license might be possible for all or any of them, the Union health ministry said on Tuesday. Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderab...

Speaking in a session of the three-day TiE Global Summit (TGS)being held virtually, Kant said the Indian startup ecosystem witnessed launch of more than 55,000 start- ups which had raised over USD 60 billion in funding in the last five years

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

The CEEW-CEF study also estimates a cumulative investment need of over $180 billion (Rs 12,50,000 crore) in vehicle production and charging infrastructure until 2030 to meet India's EV ambition